Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · IEX Real-Time Price · USD
2.600
+0.060 (2.36%)
Jul 26, 2024, 4:00 PM EDT - Market closed

Oramed Pharmaceuticals Revenue

Oramed Pharmaceuticals had revenue of $674.00K in the twelve months ending March 31, 2024, down -75.06% year-over-year. In the year 2023, Oramed Pharmaceuticals had annual revenue of $1.34M, down -50.43%.

Revenue (ttm)
$674.00K
Revenue Growth
-75.06%
P/S Ratio
156.73
Revenue / Employee
$51,846
Employees
13
Market Cap
105.64M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.34M-1.36M-50.43%
Dec 31, 20222.70M-9.00K-0.33%
Dec 31, 20212.71M9.00K0.33%
Aug 31, 20212.70M-9.00K-0.33%
Dec 31, 20202.71M2.00K0.07%
Aug 31, 2020 Pro Pro Pro
Aug 31, 2019 Pro Pro Pro
Aug 31, 2018 Pro Pro Pro
Aug 31, 2017 Pro Pro Pro
Aug 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
InterCure 97.95M
Journey Medical 80.00M
Elutia 28.99M
Omega Therapeutics 4.94M
Armata Pharmaceuticals 4.70M
I-Mab 3.90M
Sagimet Biosciences 2.00M
Cardiff Oncology 610.00K
Revenue Rankings